Literature DB >> 2301528

Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma.

H D Jampel1, D A Jabs, H A Quigley.   

Abstract

We reviewed the records of 12 eyes of ten adult patients with inflammatory glaucoma who underwent trabeculectomy with the adjuvant use of 5-fluorouracil between January 1986 and January 1989. Intraocular pressure decreased from 36 +/- 10 mm Hg (range, 17 to 50 mm Hg) preoperatively to 11 +/- 4 mm Hg (range, 3 to 17 mm Hg) postoperatively after a median follow-up of 7.75 months (range, six to 38 months). All eyes achieved an intraocular pressure of less than 20 mm Hg, and ten of 12 required no intraocular pressure lowering medications. The mean (+/- S.D.) amount of 5-fluorouracil used was 33 +/- 10 mg (range, 20 to 55 mg). During the period of observation, five of 12 eyes had an episode of uveitis, but in no patient did this result in loss of intraocular pressure control. Preoperative and postoperative systemic and topical corticosteroid use was the same. Trabeculectomy with 5-fluorouracil is an effective treatment for selected cases of adult inflammatory glaucoma refractory to medical management.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301528     DOI: 10.1016/s0002-9394(14)75982-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation.

Authors:  Shawn M Iverson; Namita Bhardwaj; Wei Shi; Mitra Sehi; David S Greenfield; Donald L Budenz; Krishna Kishor
Journal:  Jpn J Ophthalmol       Date:  2015-02-17       Impact factor: 2.447

2.  Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery.

Authors:  S Grisanti; M Diestelhorst; K Heimann; G Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

3.  Serious corneal complication of 5-fluorouracil.

Authors:  M Hickey-Dwyer; P K Wishart
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

4.  Risk factors for failures of trabeculectomies performed without antimetabolites.

Authors:  H Mietz; B Raschka; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

5.  The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma.

Authors:  Faisal A Almobarak; Ali H Alharbi; Jose Morales; Ibrahim Aljadaan
Journal:  Int Ophthalmol       Date:  2017-10-14       Impact factor: 2.031

6.  Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

Authors:  T Schlote; M Derse; M Zierhut
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

7.  Trabeculectomy ab interno with the Trabectome® as a therapeutic option for uveitic secondary glaucoma.

Authors:  Alexandra Anton; Sonja Heinzelmann; Thomas Neß; Jan Lübke; Matthias Neuburger; Jens F Jordan; Thomas Wecker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-24       Impact factor: 3.117

8.  Inflammatory glaucoma.

Authors:  Sonam A Bodh; Vasu Kumar; Usha K Raina; B Ghosh; Meenakshi Thakar
Journal:  Oman J Ophthalmol       Date:  2011-01

9.  Surgical outcomes of uveitic glaucoma.

Authors:  Ester Carreño; Sonia Villarón; Alejandro Portero; José M Herreras; José A Maquet; Margarita Calonge
Journal:  J Ophthalmic Inflamm Infect       Date:  2010-11-18

10.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.